IL123716A - Therapeutic combinations of mirtazapine and an antipsychotic agent - Google Patents

Therapeutic combinations of mirtazapine and an antipsychotic agent

Info

Publication number
IL123716A
IL123716A IL12371698A IL12371698A IL123716A IL 123716 A IL123716 A IL 123716A IL 12371698 A IL12371698 A IL 12371698A IL 12371698 A IL12371698 A IL 12371698A IL 123716 A IL123716 A IL 123716A
Authority
IL
Israel
Prior art keywords
mirtazapine
antipsychotic agent
therapeutic combinations
therapeutic
combinations
Prior art date
Application number
IL12371698A
Other languages
English (en)
Other versions
IL123716A0 (en
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL123716A0 publication Critical patent/IL123716A0/xx
Publication of IL123716A publication Critical patent/IL123716A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12371698A 1997-03-27 1998-03-17 Therapeutic combinations of mirtazapine and an antipsychotic agent IL123716A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200881 1997-03-27
EP97202785 1997-09-11

Publications (2)

Publication Number Publication Date
IL123716A0 IL123716A0 (en) 1998-12-06
IL123716A true IL123716A (en) 2001-03-19

Family

ID=26146283

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12371698A IL123716A (en) 1997-03-27 1998-03-17 Therapeutic combinations of mirtazapine and an antipsychotic agent

Country Status (25)

Country Link
EP (1) EP0969845B1 (xx)
JP (2) JP4377456B2 (xx)
KR (1) KR100577865B1 (xx)
CN (1) CN1226036C (xx)
AR (1) AR012193A1 (xx)
AT (1) ATE318604T1 (xx)
AU (1) AU726194B2 (xx)
BR (1) BR9808077A (xx)
CA (1) CA2284551C (xx)
CZ (1) CZ298105B6 (xx)
DE (1) DE69833645T2 (xx)
DK (1) DK0969845T3 (xx)
ES (1) ES2259207T3 (xx)
HK (1) HK1023293A1 (xx)
HU (1) HUP0002742A3 (xx)
ID (1) ID22283A (xx)
IL (1) IL123716A (xx)
NO (1) NO994673L (xx)
NZ (1) NZ337618A (xx)
PL (1) PL191449B1 (xx)
PT (1) PT969845E (xx)
RU (1) RU2222330C2 (xx)
TR (1) TR199902334T2 (xx)
TW (1) TW587938B (xx)
WO (1) WO1998043646A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
FR2797399B1 (fr) * 1999-08-13 2002-10-18 Aventis Pharma Sa Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines
US6350773B1 (en) 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
FR2802101B1 (fr) * 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
HUP0204050A3 (en) * 2000-01-19 2004-09-28 Akzo Nobel Nv Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
EP1795199A3 (en) * 2001-02-06 2007-07-25 AstraZeneca AB Quetiapine for the treatment of substance dependence or substance abuse
DE60219761T2 (de) 2001-02-06 2008-01-17 Astrazeneca Ab Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
TW200517106A (en) 2003-10-29 2005-06-01 Wyeth Corp Sustained release pharmaceutical compositions
EP1708790B1 (en) * 2003-12-02 2010-04-21 PharmaNeuroBoost N.V. Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders
EP1547650A1 (en) * 2003-12-02 2005-06-29 B & B Beheer NV Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7855195B2 (en) 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7884096B2 (en) 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
PT1541197E (pt) * 2003-12-02 2009-06-04 Pharmaneuroboost N V Utilização de pipamperona e de um sndri, snri ou ssri para o tratamento de patologias do temperamento ou da ansiedade
RU2006146612A (ru) 2004-06-03 2008-07-20 Ф.Хоффманн-Ля Рош Аг (Ch) Лечение цисплатином и ингибитором рецептора эпидермального фактора роста (egfr)
KR101390012B1 (ko) * 2006-06-09 2014-04-29 다이닛본 스미토모 세이야꾸 가부시끼가이샤 신규한 테이프 제제
JOP20120083B1 (ar) * 2011-04-05 2021-08-17 Otsuka Pharma Co Ltd توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns
DE102012011839B4 (de) 2012-06-14 2018-03-22 Norbert Müller Verwendung von Interferon-gamma in einem Verfahren zur Behandlung von psychiatrischen Erkrankungen
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
DE69005992T2 (de) * 1989-12-06 1994-05-05 Akzo Nv Psychotropische Wirkstoffe enthaltende stabilisierte Lösungen.
ZA935078B (en) * 1992-07-15 1994-02-07 Nicolaas Johannes Jaco Loetter Pharmaceutical composition
PT669128E (pt) * 1992-11-17 2000-06-30 Yoshitomi Pharmaceutical Micro-esfera de libertacao sustentada contendo antipsicoticos e processo para produzir a mesma
JPH07242669A (ja) * 1994-03-07 1995-09-19 Akikazu Ogawa 四環系とブチロフェノン誘導体を化学結合した化合物

Also Published As

Publication number Publication date
HUP0002742A3 (en) 2003-03-28
CN1226036C (zh) 2005-11-09
BR9808077A (pt) 2000-03-08
ID22283A (id) 1999-09-30
DE69833645T2 (de) 2006-08-24
KR20010005677A (ko) 2001-01-15
AU726194B2 (en) 2000-11-02
PT969845E (pt) 2006-05-31
HUP0002742A2 (hu) 2001-05-28
CA2284551A1 (en) 1998-10-08
NO994673D0 (no) 1999-09-24
KR100577865B1 (ko) 2006-05-10
EP0969845A1 (en) 2000-01-12
WO1998043646A1 (en) 1998-10-08
NO994673L (no) 1999-11-17
DE69833645D1 (de) 2006-04-27
TW587938B (en) 2004-05-21
ES2259207T3 (es) 2006-09-16
CA2284551C (en) 2007-06-12
PL191449B1 (pl) 2006-05-31
PL335890A1 (en) 2000-05-22
CN1251526A (zh) 2000-04-26
JP5023315B2 (ja) 2012-09-12
IL123716A0 (en) 1998-12-06
JP2009280596A (ja) 2009-12-03
RU2222330C2 (ru) 2004-01-27
JP2001521497A (ja) 2001-11-06
CZ298105B6 (cs) 2007-06-27
DK0969845T3 (da) 2006-06-19
JP4377456B2 (ja) 2009-12-02
EP0969845B1 (en) 2006-03-01
HK1023293A1 (en) 2000-09-08
NZ337618A (en) 2000-06-23
CZ343199A3 (cs) 2000-04-12
TR199902334T2 (xx) 2000-01-21
AU7213998A (en) 1998-10-22
AR012193A1 (es) 2000-09-27
ATE318604T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
IL123716A (en) Therapeutic combinations of mirtazapine and an antipsychotic agent
PL344977A1 (en) Therapeutic uses of quinoline derivatives
PL326744A1 (en) Therapeutic sock and method of making same
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
PL330235A1 (en) Derivatives of spiropiperidine and their application as therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
IL116590A0 (en) 3-phenylisoquinol-1(2h)-one derivatives their preparation and their therapeutic application
ZA985253B (en) Quinolines and their therapeutic use
GB9702392D0 (en) Therapeutic agents
ZA982362B (en) Quinolin-2-(1h)-one and dihydroquinolin-2-(1h)-one derivatives their preparation and their therapeutic application
HUP9800146A3 (en) Thalidomide-derivatives and use of them
GB9700555D0 (en) Therapeutic agents
GB9824160D0 (en) Heterocyclic compounds and their therapeutic use
GB9716463D0 (en) Therapeutic agents
PL338862A1 (en) Derivatives of 2-oxypyroimidin-4-one and 2-oxypyroimidin-4-thione
GB9713240D0 (en) Heterocyclic compounds and their therapeutic use
SI1014974T1 (en) Treatment of schizophrenia and psychosis
GB9714298D0 (en) Quinolines and their therapeutic use
GB9820768D0 (en) Heterocyclic compounds and their therapeutic use
GB9819505D0 (en) Heterocyclic compounds and their therapeutic use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees